Portfolio company
Anto Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Anto
This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.
Axiom Bio
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
Outpost Bio
This company builds machine learning models of the human microbiome to help pharmaceutical and consumer health teams predict drug interactions and ingredient efficacy.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
Cellular Intelligence
This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.
BioCorteX
This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.
Outpost
The company develops microbiome models using machine learning to help drug and food research teams predict biological interactions and assess development risks.
